HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact Assessment surveys in sub-Saharan Africa
-
Published:2024-04-04
Issue:4
Volume:4
Page:e0003030
-
ISSN:2767-3375
-
Container-title:PLOS Global Public Health
-
language:en
-
Short-container-title:PLOS Glob Public Health
Author:
Edun OlanrewajuORCID, Okell LucyORCID, Chun HelenORCID, Bissek Anne-Cecile Z., Ndongmo Clement B.ORCID, Shang Judith D.ORCID, Brou Hermann, Ehui Eboi, Ekra Alexandre K.ORCID, Nuwagaba-Biribonwoha Harriet, Dlamini Sindisiwe S., Ginindza Choice, Eshetu Frehywot, Misganie Yimam G.ORCID, Desta Sileshi LulsegedORCID, Achia Thomas N. O.ORCID, Aoko AppoloniaORCID, Jonnalagadda SasiORCID, Wafula RoseORCID, Asiimwe Fred M.ORCID, Lecher ShirleyORCID, Nkanaunena KondwaniORCID, Nyangulu Mtemwa K., Nyirenda Rose, Beukes AnitaORCID, Klemens Johannes O.ORCID, Taffa Negussie, Abutu Andrew A.ORCID, Alagi MatthiasORCID, Charurat Man E.ORCID, Dalhatu IbrahimORCID, Aliyu Gambo, Kamanzi CollinsORCID, Nyagatare CelestineORCID, Rwibasira Gallican N.ORCID, Jalloh Mohamed F.ORCID, Maokola Werner M., Mgomella George S.ORCID, Kirungi Wilford L., Mwangi ChristinaORCID, Nel Jennifer A.ORCID, Minchella Peter A.ORCID, Gonese GloriaORCID, Nasr Melodie A., Bodika Stephane, Mungai ElisabethORCID, Patel Hetal K., Sleeman KatrinaORCID, Milligan KyleORCID, Dirlikov EmilioORCID, Voetsch Andrew C.ORCID, Shiraishi Ray W.ORCID, Imai-Eaton Jeffrey W.ORCID
Abstract
As antiretroviral treatment (ART) coverage for people living with HIV (PLHIV) increases, HIV programmes require up-to-date information about evolving HIV risk behaviour and transmission risk, including those with low-level viremia (LLV; >50 to ≤1000 copies/mL), to guide prevention priorities. We aimed to assess differences in sexual risk behaviours, distribution of viral load (VL) and proportion of transmission across PLHIV subgroups. We analysed data from Population-based HIV Impact Assessment surveys in 14 sub-Saharan African countries during 2015–2019. We estimated adjusted prevalence ratios (aPR) of self-reported HIV high-risk behaviour (multiple partners and condomless sex) across cascade stages via generalised estimation equations. We modelled the proportions of transmission from each subgroup using relative self-reported sexual risk, a Hill function for transmission rate by VL, and proportions within cascade stages from surveys and UNAIDS country estimates for 2010–2020. Compared to PLHIV with undetectable VL (≤50 copies/mL), undiagnosed PLHIV (aPR women: 1.28 [95% CI: 1.08–1.52]; men: 1.61 [1.33–1.95]) and men diagnosed but untreated (2.06 [1.52–2.78]) were more likely to self-report high-risk sex. High-risk behaviour was not significantly associated with LLV. Mean VL was similar among undiagnosed, diagnosed but untreated, and on ART but non-suppressed sub-groups. Across surveys, undiagnosed and diagnosed but untreated contributed most to transmission (40–91% and 1–41%, respectively), with less than 1% from those with LLV. Between 2010 and 2020, the proportion of transmission from individuals on ART but non-suppressed increased. In settings with high ART coverage, effective HIV testing, ART linkage, and retention remain priorities to reduce HIV transmission. Persons with LLV are an increasing share of PLHIV but their contribution to HIV transmission was small. Improving suppression among PLHIV on ART with VL ≥1000 copies/mL will become increasingly important.
Funder
Wellcome Trust Medical Research Foundation Bill and Melinda Gates Foundation
Publisher
Public Library of Science (PLoS)
Reference44 articles.
1. Joint United Nations Programme on HIV/AIDS (UNAIDS). HIV estimates with uncertainty bounds 1990-Present. 2023 [cited 25 May 2022]. https://www.unaids.org/en/resources/documents/2021/HIV_estimates_with_uncertainty_bounds_1990-present 2. World Health Organization. Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring. 2021 [cited 17 Jul 2021]. https://www.who.int/publications/i/item/9789240022232 3. Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients;P Ryscavage;Antimicrob Agents Chemother,2014 4. Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy;MN Neely;J Acquir Immune Defic Syndr,2007
|
|